# A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

> **NCT06214741** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 307 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** survodutide
- **DRUG:** Placebo matching BI 456906

## Key facts

- **NCT ID:** NCT06214741
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-06
- **Primary completion:** 2025-07-29
- **Final completion:** 2026-01-28
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214741, "A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06214741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*